UMS member, Dr Douiri publishes in Journal of Clinical Pathology

Dr Douiri, along with other colleagues from King’s College Hospital NHS Foundation trust and King’s College London, have published as study titled:

Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants—single centre pilot study

The study published in the Journal of Clinical Pathology evaluated the ‘clinical utility of a composite biomarker panel to help identify individuals at risk of developing aGVHD, and to help predict and differentiate between severity of aGVHD following T-cell-depleted allogeneic HSCT’.

The retrospective cohort study concluded that the ‘pilot data support the usefulness of these composite biomarker panels in the prediction of severity and diagnosis of aGVHD in patients undergoing T-cell-depleted reduced intensity allogeneic HSCT’.

 

Advertisements